SG Americas Securities, LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 187 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$79
+338.9%
96,073
+714.3%
0.00%
Q4 2022$18
-100.0%
11,798
-83.5%
0.00%
-100.0%
Q3 2022$123,000
-78.6%
71,417
-78.6%
0.00%
-66.7%
Q2 2022$576,000
+428.4%
332,971
+995.0%
0.01%
+500.0%
Q1 2022$109,000
-61.6%
30,407
-46.5%
0.00%
-50.0%
Q4 2021$284,000
-76.8%
56,821
-66.7%
0.00%
-66.7%
Q3 2021$1,222,000
+1109.9%
170,739
+1464.5%
0.01%
Q2 2021$101,000
-70.2%
10,913
-70.1%
0.00%
-100.0%
Q1 2021$339,000
-1.2%
36,482
-5.9%
0.00%0.0%
Q4 2020$343,000
-60.7%
38,781
-48.5%
0.00%
-66.7%
Q3 2020$873,000
-8.2%
75,255
+113.3%
0.01%
-25.0%
Q2 2020$951,000
+288.2%
35,283
+7.2%
0.01%
+300.0%
Q1 2020$245,000
-14.3%
32,902
-62.0%
0.00%
-33.3%
Q4 2019$286,000
+102.8%
86,559
+25.7%
0.00%
+200.0%
Q3 2019$141,000
+252.5%
68,842
+545.1%
0.00%
Q1 2019$40,000
-2.4%
10,672
+0.9%
0.00%
Q2 2018$41,000
-60.2%
10,575
-34.7%
0.00%
-100.0%
Q3 2017$103,000
+25.6%
16,194
+54.2%
0.00%0.0%
Q2 2017$82,000
-53.9%
10,504
-45.0%
0.00%
-50.0%
Q3 2016$178,000
+87.4%
19,083
+75.4%
0.00%
+100.0%
Q1 2016$95,000
-29.1%
10,879
-25.7%
0.00%0.0%
Q4 2014$134,000
-7.6%
14,644
+9.1%
0.00%0.0%
Q2 2014$145,00013,4190.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
CAXTON ASSOCIATES LP 784,679$643,4370.10%
Green Alpha Advisors, LLC 146,300$119,9660.08%
Virtus ETF Advisers LLC 54,106$44,3670.02%
Cedar Brook Financial Partners, LLC 104,881$86,0020.02%
PROFUND ADVISORS LLC 418,749$343,3740.02%
Arlington Capital Management, Inc. 27,735$22,7430.02%
Hennion & Walsh Asset Management, Inc. 382,158$3130.02%
Rafferty Asset Management, LLC 2,647,927$2,171,3000.02%
Brainard Capital Management LLC 16,666$13,6660.01%
Beck Bode, LLC 41,218$33,7990.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders